| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-1-B glycoprotein | 0.700 | 0.538 | 5.0E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Alzheimer disease-11 | 0.722 | 0.462 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
microRNA 1228 | 0.769 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 4262 | 0.722 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
occludin | 0.507 | 0.846 | 8.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||
|
endogenous retrovirus group K member 2 | 0.674 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
endogenous retrovirus group K member 12 | 0.678 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
endogenous retrovirus group K member 22 | 0.678 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
H3 histone pseudogene 12 | 0.603 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
long intergenic non-protein coding RNA 554 | 0.890 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
endogenous retrovirus group K member 11 | 0.663 | 0.423 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
long intergenic non-protein coding RNA 210 | 0.792 | 0.192 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
PGR antisense RNA 1 | 0.514 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
serum/glucocorticoid regulated kinase 2 | 0.780 | 0.192 | 2.2E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
actin related protein 1A | 0.792 | 0.423 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
ADP ribosylation factor like GTPase 4C | 0.656 | 0.308 | 0.76 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leucine rich pentatricopeptide repeat containing | 0.493 | 0.769 | 2.3E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
ADP ribosylation factor related protein 1 | 0.729 | 0.500 | 0.14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
cadherin 17 | 0.636 | 0.615 | 3.4E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
lysophosphatidic acid receptor 6 | 0.678 | 0.385 | 7.1E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
zinc finger protein 197 | 0.606 | 0.615 | 5.2E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 |